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Abstract
Background: Little is known about the differences among adult and foetal equine mesenchymal stem cells (MSCs),
and no data exist about their comparative ultrastructural morphology. The aim of this study was to describe and
compare characteristics, immune properties, and ultrastructural morphology of equine adult (bone marrow: BM, and
adipose tissue: AT) and foetal adnexa derived (umbilical cord blood: UCB, and Wharton’s jelly: WJ) MSCs.
Results: No differences were observed in proliferation during the first 3 passages. While migration ability was
similar among cells, foetal MSCs showed a higher adhesion ability, forming smaller spheroids after hanging drop
culture (P < 0.05). All MSCs differentiated toward adipogenic, chondrogenic and osteogenic lineages, only tenogenic
differentiation was less evident for WJ-MSCs. Data obtained by PCR confirmed MHC1 expression and lack of MHC2
expression in all four cell types. Foetal adnexa MSCs were positive for genes specific for anti-inflammatory and
angiogenic factors (IL6, IL8, ILβ1) and WJ-MSCs were the only positive for OCT4 pluripotency gene. At immunofluorescence
all cells expressed typical mesenchymal markers (α-SMA, N-cadherin), except for BM-MSCs, which did not express
N-cadherin. By transmission electron microscopy, it was observed that WJ-MSCs had a higher (P < 0.05) number of
microvesicles compared to adult MSCs, and UCB-MSCs showed more microvesicles than BM-MSCs (P < 0.05).
AT-MSCs had a lower number of mitochondria than WJ-MSCs (P < 0.05), and mitochondrial area was higher for
WJ-MSCs compared to UCB and AT-MSCs (P < 0.05).
Conclusions: Results demonstrate that MSCs from adult and foetal tissues have different characteristics, and foetal
MSCs, particularly WJ derived ones, seem to have some charactestics that warrant further investigation into potential
advantages for clinical application.
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Background
Mesenchymal stem cells (MSCs), also known as multipo-
tent stromal cells or mesenchymal progenitor cells, are of
increasing interest in the regenerative medicine field.
Populations of MSCs can be relatively easily isolated from
tissues that differ both developmentally (e.g., foetal versus
adult) and anatomically (e.g., bone marrow versus adipose
tissue). Despite the common characterization and clinical
applicability potential for all the different sources of MSCs,
there are qualitative and quantitative differences in terms
of their isolation efficiency and in vitro manipulation
performance, as well as their efficacy in animal models and
clinical studies, which have been highlighted both in
human [1–5] and animals [6–11]. Diversity in cell manipu-
lation, including the isolation and culture protocols
applied, in addition to inherent heterogeneity in the sam-
ples related to donor, may have an impact on the quality
and quantity of isolated cells. Therefore, issues concerning
ease of isolation, cell yield, and donor site complications
suggest that certain sources may be more favorable than
others for a specific clinical application.
In the horse, MSCs from bone marrow (BM) possessed
the highest in vitro osteogenic potential compared to
adipose tissue (AT) and umbilical cord blood (UCB) and
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tissue (UCT) as indicated by osteogenic gene expression
and mineral deposition [6]. Burk et al. (2013) confirmed
the same observation but noticed that, in contrast, the
highest levels of chondrogenic differentiation were ob-
served in UCB- and UCT-MSCs [7]. On the other hand,
AT-MSCs showed the highest expression of tendon
extracellular matrix proteins and tendon differentiation
markers [10]. When comparing BM to amnion derived
MSCs, the placental cells showed a more rapid growth
and clonogenic capability and a faster osteogenic differ-
entiation [8]. In vivo application for treatment of horse
tendon and ligament injuries of BM and amniotic
membrane MSCs not only confirmed the advantage to
administer allogeneic amniotic membrane MSCs when
needed, before any ultrasonographic change occurs
within the injured tendon and ligament, but also the
lower re-injury rate observed after amniotic MSCs treat-
ment let suppose that their implantation is more effica-
cious compared to BM-MSCs implantation [9].
Despite the investigations, still little is known about
the differences among adult and foetal adnexa derived
MSCs, and no data exist about their comparative ultra-
structural morphology. Since different foetal adnexa
derived equine MSCs showed ultrastructural differences
[12], the aim of this study was to describe and compare
expression of markers related to characterization and
paracrine activity, and ultrastructural morphology of
equine post-natal adult (BM and AT) and foetal adnexa
derived (UCB and Wharton’s jelly-WJ) MSCs.
Results
Cell isolation and calculation of cell doubling times
Adherent mononuclear cells were characterized by a
homogeneous elongated fibroblast-like morphology. Un-
differentiated cells of different sources were passaged up
to three times; no changes in cell morphology were ob-
served throughout the culture period.
Considering data from 3 passages, no differences (P >
0.05) were observed in CDs (cell doublings) of different
cell types (8.6 ± 0.4 vs. 9.0 ± 1.4 vs. 9.6 ± 0.9 vs. 9.9 ± 1.1
for BM, AT, UCB and WJ respectively). Mean DT (doub-
ling time) was similar (P > 0.05) among groups (3.6 ± 1.4
days vs. 2.2 ± 1. 1 days vs 2.4 ± 1.3 days vs. 2.7 ± 0.9 days
for BM, AT, UCB and WJ respectively).
Comparing data from single passages of the same cell
type, no statistically significant differences were found in
DTs (P > 0.05).
Adhesion and migration assays
Both foetal and adult MSCs formed spheroids when
cultured in hanging drops (Fig. 1). Average volume
of the spheroids formed by WJ and UCB-MSCs was
significantly lower (P < 0.05) as compared to BM and
AT-MSCs, demonstrating a higher cell-cell adhesion
capacity for foetal adnexa derived MSCs than adult
MSCs.
Probably due to the large variation observed for AT-
MSCs, average percentage of migration, observed by
scratch test, was similar (P > 0.05) between cell types
(WJ-MSCs 43.0 ± 7.7%, UCB-MSCs 28.4 ± 5.0%, BM-
MSCs: 25.0 ± 10.2%, AT-MSCs 24.5 ± 21.4%) when ana-
lysed by one-way ANOVA. Comparison of groups using
a Student T-test, revealed a higher (P < 0.05) migration
rate for WJ-MSCs than for UCB and BM-MSCs, but not
compared to AT-MSCs (P > 0.05), as could be expected
due to the large variation observed in this group.
In vitro differentiation
All cell types were able to differentiate toward osteo-
genic (Fig. 2), chondrogenic (Fig. 3), adipogenic direction
(Fig. 4). Subjective observation could not find obvious
differences among groups, but it is interesting to report
that, even if cultured in monolayer for chondrogenic dif-
ferentiation, UCB-MSCs tended to form a mass of differ-
entiated cells in the dish. For this reason it was possible
to get images only of the few cells still in mono-layer
(Fig. 3a). It could suggest that UCB-MSCs have a very
good potential for chondrogenic differentiation. For
tenogenic differentiation (Fig. 5) WJ-MSCs showed poor
morphology changes when compared to the other cell
lines.
Immunofluorescence (IF)
Both adult and foetal cell types clearly expressed the
mesodermal marker α-SMA (α-smooth muscle actin,
Fig. 6a, c, e, g). On the contrary, BM-MSCs did not ex-
press the mesenchymal marker N-Cadherin while UCB,
WJ and AT-MSCs did (Fig. 6b, d, f, h).
Fig. 1 Adhesion assay results. Spheroids derived from equine bone
marrow (BM), adipose tissue (AT), Wharton’s jelly (WJ) and umbilical
cord blood (UCB) mesenchymal stem cells after 24 h hanging drop
culture. Spheroids were reconstructed and visualized from a single
projection using ReViSP. Measure unit: pixel
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Fig. 2 Equine mesenchymal stem cells (MSCs) osteogenic differentiation. Von Kossa staining of extensive extracellular mineral deposition in MSCs
derived from umbilical cord blood (a) (bar: 100 μm), Wharton’s jelly (b) (bar: 100 μm), bone marrow (c) (bar: 100 μm) and adipose tissue (d) (bar: 100 μm)
Fig. 3 Equine mesenchymal stem cells (MSCs) chondrogenic differentiation. Alcian Blue staining of glycosaminoglycans in cartilage matrix in
MSCs derived from umbilical cord blood (a) (bar: 50 μm), Wharton’s jelly (b) (bar: 50 μm), bone marrow (c) (bar: 100 μm) and adipose tissue (d)
(bar: 200 μm)
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Reverse transcriptase-polymerase chain reaction (RT-PCR)
Qualitative data (presence/absence) obtained by PCR are
reported in Table 1. All cell types were positive for MSC
marker CD90, while AT-MSCs were negative for CD73.
All cells were negative for hematopoietic markers CD34
and CD45, except for WJ-MSCSs, that were positive for
CD34. MHC1 was positive and MHC2 negative for all
cell types. Only WJ and UCB-MSCs were positive for
IL6 and IL8, and WJ-MSCs also for ILβ1. IL-4, TNFα
and INFγ were not constitutively expressed in any cell
type. All cells were negative for pluripotency markers
except for WJ-MSCs that were positive for OCT4.
Transmission Electron microscopy (TEM) and
morphometric analysis
UCB-MSCs showed a fibroblast shape morphology
(Fig. 7a) with the nucleus and nucleoli well detected. In
the cytoplasm several organelles, such as Golgi appar-
atus, surrounded by several vesicles (Fig. 7b), a wide-
spread rough endoplasmic reticulum (RER) (Fig. 7c)
and narrow mitochondria, with dense matrix and thin
cristae, (Fig. 7d) were detected. Lipid droplets (Fig. 7a)
and multivesicular bodies (Fig. 7b) were also observed
in the cytoplasm.
WJ-MSCs appeared with a spindle like morphology
(Fig. 7e). Nucleus and compact and thick nucleoli were
easily detected (Fig. 7e). At higher magnification, regular
RER, lipid droplets and Golgi apparatus, closed around by
several vesicles were observed (Fig. 7f and g). Mitochondria
appeared scattered in the cytoplasm (Fig. 7h).
BM-MSCs showed a fibroblast shape morphology (Fig. 8a)
with nucleus and dense nucleoli easily detectable. Golgi
apparatus, surrounded by several vesicles (Fig. 8b), scattered
extensively in the cytoplasm. RER with dilated cisternae
was observed (Fig. 8c), characterized by membranes almost
lacking ribosomes. Mitochondria were detected in each cell
section (Fig. 8c). Several extracellular vesicles and exosomes
were observed in the extracellular membrane surface
(Fig. 8d).
AT-MSCs showed a fibroblast like morphology (Fig. 8e)
with nuclei and nucleoli well detected. A scattered Golgi
complex, surrounded by vesicles (Fig. 8f ) was observed.
Mitochondria were present in the cell (Fig. 8f ). The RER
is localized in one end of the cell and it is characterized
by enlarged membrane, almost free from ribosomes
(Fig. 8g). Several extracellular vesicles were detected on
membrane surface (Fig. 8h).
Total results from morphometric analysis are summa-
rized in Fig. 9. The number of microvesicle was signifi-
cantly higher (P < 0.05) for WJ-MSCs compared to adult
MSCs and for UCB-MSCs compared to BM-MSCs
(Fig. 9c). Also the number and area of mitochondria were
different, since AT-MSCs had a lower number of mito-
chondria than WJ-MSCs (P < 0.05) (Fig. 9f) and WJ-MSCs
showed a higher (P < 0.05) mitochondrial area compared
to UCB and AT-MSCs (Fig. 9g).
Fig. 4 Mesenchymal stem cells (MSCs) adipogenic differentiation. Oil red O staining of extensive intracellular lipid droplet accumulation in MSCs derived
from umbilical cord blood (a) (bar: 100 μm), Wharton’s jelly (b) (bar: 100 μm), bone marrow (c) (bar: 100 μm) and adipose tissue (d) (bar: 100 μm)
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Discussion
In this study, MSCs from foetal adnexa (UCB and WJ)
and adult tissues (BM and AT) were isolated and many
features were compared: proliferation, migration, spher-
oids formation, differentiation capacity, expression of
relevant markers and ultrastructural features. All isolated
cells showed the typical mesenchymal morphology. Both
foetal adnexa and adult MSCs were isolated, cultivated
with standard protocols and they did not show differ-
ences for CD and DT. However, in this study, we consid-
ered only the first three passages of culture, in fact it has
been already demonstrated that WJ had a shorter DT
than UCB when analysing data derived from a longer
period of culture (8 passages) [13]. In this study, only 3
passages were considered since for clinical application
only early passages are usually used to avoid any effect
of cellular senescence or transformation.
Migration potential of MSCs is considered import-
ant for their integration into the host tissue during
therapeutic applications [14]. In the present study,
WJ-MSCs showed a higher migration activity com-
pared to UCB and BM-MSCs, but not compared to
AT-MSCs, due to the high variability observed among
samples in that group. The higher migration potential
could suggest that WJ-MSCs graft integration in vivo may
be enhanced.
Fig. 5 Equine mesenchymal stem cells (MSCs) tenogenic differentiation. Staining with Aniline Blue method of umbilical cord blood (UCB)-MSCs
control cells (a) (bar: 100 μm) and differentiated cells (b) (bar: 100 μm), Wharton’s jelly (WJ)-MSCs control cells (c) (bar: 100 μm) and differentiated
cells (d) (bar: 100 μm), bone marrow (BM)-MSCs control cells (e) (bar: 100 μm) and differentiated cells (f) (bar: 100 μm) and adipose tissue (AT)-
MSCs control cells (g) (bar: 100 μm) and differentiated cells (h) (bar: 100 μm)
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At P3 all cells were differentiated to evaluate their osteo-
genic, chondrogenic, adipogenic and tenogenic potential.
While morphological changes and differences after stain-
ings showed similar differentiation ability of both foetal
adnexa derived and adult MSCs toward osteogenic, chon-
drogenic and adipogenic lineages, tenogenic differentiation
was less evident for WJ-MSCs as compared to the other
MSCs. Since it is the first time that equine WJ-MSCs are
differentiated toward tendon with the protocol used, it is
still not clear if the difference is due to a not suitable teno-
genic induction protocol or because these cells need a
longer stimulation period.
In the present study, the cell-cell adhesion capabil-
ity was measured by the in vitro spheroid formation
potential using the hanging drop method. As already
demonstrated, adhesion ability can be related to the
chondrogenic differentiation potential [15–17]. De-
termining the spheroid volume (a smaller volume is
related to a higher cell-cell adhesion ability), it was
evident that foetal adnexa derived MSCs had a
higher adhesion ability than adult cells, being able to
form smaller spheroids. Cells derived from UCB cre-
ated multiple small spheroids and were not able to
give origin to a single spheroid per drop.
Fig. 6 Photomicrographs of immunostaining of umbilical cord blood (UCB), Wharton’s jelly (WJ), bone marrow (BM) and adipose tissue (AT)-MSCs
(mesenchymal stem cells). Expression of the mesenchymal marker α-SMA in the UCB (a) (bar: 50 μm), WJ (c) (bar: 50 μm), BM (e) (bar: 50 μm) and
AT-MSCs (g) (bar: 50 μm). Expression of the mesenchymal marker N-Cadherin in the UCB (b) (bar: 50 μm), WJ (d) (bar: 50 μm), BM (f) (bar: 50 μm)
and AT-MSCs (h) (bar: 50 μm). Green is FITC from each target marker and blue is nuclei staining with Hoechst 33342 (UCB and WJ-MSCs) or DAPI
(BM and AT-MSCs)
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Immunofluorescence investigation showed a positive ex-
pression of α-SMA in all cell types, a protein expressed by
cells of the mesodermal lineage [18]. However, BM-MSCs
did not express N-Cadherin, another mesenchymal
marker [18]. It can be speculated that BM-MSCs loose N-
Cadherin expression during culture, since in another study
regarding immunophenotypic characterization of equine
BM-MSCs, it was observed that N-cadherin-positive cells
were present at the second passage, whereas at the fifth
passage these cells were not detected [19].
Equine MSCs from all tested sources expressed the
genes coding for positive marker antigens and did not
express genes coding for the negative marker as defined
by the International Society for Cellular Therapy [20].
As previously observed [12], equine WJ-MSCs were
positive for CD34. As recently demonstrated, the expres-
sion of CD34 seems to depend on the environment, on
the in vitro culture cell passages and on the cell source
[21, 22], supporting that the lack of CD34 marker can
not be considered an essential requirement of a stem
cell. AT-MSCs were negative for CD73, but as already
demonstrated by flow cytometry, CD73 is rarely
expressed by most equine MSCs [22–26]. Our results
are based only on positive/negative gene expression but
not on relative quantification of gene expression or in
protein expression by flow cytometry or other tech-
niques, which means that surface marker expression
may differ from qualitative gene expression.
Foetal cells were unique in that they expressed some
interleukins (IL8 and IL6 for both WJ and UCB-MSCs,
ILβ1 for WJ-MSCs only). All the cells were negative for
TNFα, IL4 and INFγ, cytokines that may be produced
only after in vitro stimulation [27]. ILβ1, IL6 and IL8 are
important mediators of the inflammatory response,
involved in a variety of cellular activities, including cell
proliferation, differentiation, apoptosis, chemotaxis,
angiogenesis and haematopoiesis [28]. These factors are
involved in the complex interaction between MSCs and
the tissue microenvironment as well as production of
membrane vesicles, containing molecules such as short
peptides, proteins, lipids, and various forms of RNAs
[29]. These findings encourage investigation in potential
advantages of foetal adnexa derived MSCs for therapy.
As for SOX2 and NANOG, OCT4 is a typical marker
of embryonic pluripotent cells [30–34] and it should not
be expressed by MSCs. However, its expression by WJ-
MSCs confirms their intermediate characteristics be-
tween adult and embryonic stem cells [35]. Although the
OCT4 primer used in the present study was chosen
from a research in which also immunofluorescent local-
isation of Oct4 protein was made on equine embryos
[36], it has been demonstrated in human, mouse and pig
that Oct4 has different variants [37–39] and that detec-
tion of Oct4 expression by RT-PCR could be prone to
artifacts generated by pseudogene transcripts [40]. No
specific research on equine Oct4 is available, therefore
western blotting could be used in future work to further
support our conclusions in the present study.
TEM morphological analysis of MSCs showed ultra-
structural details connected with the different origin of
cells. A fibroblast shape morphology, dense nucleoli, a
widespread Golgi apparatus and well developed RER are
morphological features linked to the mesenchymal
phenotype [41, 42]. Golgi complex and RER are strictly
connected with a high protein synthesis and high meta-
bolic rate [41, 42]. The elevated secreting ability of these
cells is further underlined either by the presence of
several extracellular vesicles and exosomes, on cell sur-
face, and multivesicular bodies, inside the cells, which
are released in the extracellular microenvironment and
act as paracrine factors [42]. Foetal adnexa MSCs, in
particular WJ derived ones, showed a larger amount of
microvesicles in the cytoplasm compared to adult MSCs.
The presence of a constitutive autophagy has been dem-
onstrated as a cytoprotective and cellular quality control
mechanisms to balance protein and organelle turnover,
crucial for the maintenance of stemness and for a
Table 1 Results obtained by PCR running on equine foetal
adnexa derived and adult mesenchymal stem cells (MSCs).
Qualitative data (presence/absence) are presented, grouped in
categories
Primers WJ-MSCs UCB-MSCs BM-MSCs AT-MSCs
Mesenchymal markers
CD90 + + + +
CD73 + + + –
Hematopoietic markers
CD34 + – – –
CD45 – – – –
Major histocompatibility complex markers
MHC1 + + + +
MHC2 – – – –
Pro- and anti-inflammatory citokines
TNFα – – – –
IL8 + + – –
INFγ – – – –
IL4 – – – –
ILβ1 + – – –
IL6 + + – –
Pluripotency markers
OCT4 + – – –
NANOG – – – –
SOX2 – – – –
WJ Wharton’s jelly, UCB umbilical cord blood, BM bone marrow, AT adipose
tissue. +: positive; −: negative
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number of differentiation processes [43, 44]. Further-
more, the therapeutic potential of mesenchymal stem cell-
derived microvesicles has been largely demonstrated [45],
which could confer a potential advantage to foetal adnexa
MSCs for therapeutic use, even though these results are still
preliminary.
Equine MSCs presented few mitochondria in each cell,
with a long and narrow morphology. In all samples,
mitochondria showed a very long and narrow shape,
with a dense matrix and thin cristae, in agreement with
in vitro cultured stem cells [46]. During stem cell deriv-
ation, a shift from orthodox mitochondria, with a char-
acteristic light matrix and thin cristae, to condensed
mitochondria, with a dense matrix and swollen cristae,
has been described and it is thought to be connected
with a decrease of membrane potential, increased oxy-
gen and ADP/ATP ratio [46]. In detail, WJ-MSCs, with a
high number of mitochondria and the larger mean mito-
chondrial area of 0,40 μm2, reached the highest value
suggesting a higher energy requirements [47, 48] for
Fig. 7 TEM analysis of equine foetal adnexa derived mesenchymal stem cells (MSCs). Umbilical cord blood MSCs (a) Cells show a fibroblast like
morphology. Nucleus (N) and dark and dense nucleoli (n) are well detected (bar: 10 μm); b Golgi complex (black arrow), lipid droplets (li) and
multivesicular bodies (black arrowhead) are observed in the cytoplasm (bar: 1 μm); c A well-developed RER, with long and narrow membranes,
localized in the cytoplasm (bar: 1 μm); d Long and narrow mitochondria (m), with dense matrix and thin cristae, are observed in the cytoplasm
(bar: 500 nm). Wharton’s jelly MSCs (e) low magnification image showing a cluster of MSCs with a spindle morphology. Nucleus (N) and dark and
dense nucleoli (n) are easily detected (bar: 10 μm); f RER (rer), Golgi apparatus (black arrow), mitochondria (m) and lipid droplets (black arrow)
were observed in the cytoplasm (bar: 1 μm); g detail of the cytoplasm showing a well-developed RER (rer) and Golgi complex (black arrow)
surrounded by several vesicles and mitochondria (m) (bar: 500 nm); h Long and narrow mitochondria (m), with dense matrix and thin cristae, are
observed in the cytoplasm (bar: 500 nm)
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WJ-MSCs needed for Golgi complex, protein synthesis
and cell expansion.
Conclusion
Taking together all the results, they warrant further
investigation of therapeutic potential of foetal adnexa
derived equine MSCs, particularly WJ-MSCs. The teno-
genic differentiation ability of WJ-MSCs remains to be
elucidated. While reduced tenogenic potential may be
inconvenient, their therapeutic use in case of tendon
injuries should be further investigated, since different
factors play a role in therapeutic application beyond
differentiation ability.
Methods
Chemicals were purchased from Sigma-Aldrich (Milan,
Italy), and laboratory plastic ware from Sarstedt Inc.
(Verona. Italy), unless otherwise stated.
Fig. 8 TEM analysis of equine adult mesenchymal stem cells (MSCs). Bone marrow MSCs (a) Cells show a fibroblast like morphology.
Nucleus (N) and dark and dense nucleoli (n) are well detected (bar: 20 μm); b A well-developed Golgi complex surrounded by several
vesicles and multivesicular bodies (white square; bar: 500 nm) are observed in the cytoplasm (bar: 1 μm); c Extended RER (rer),
characterized by dilated cisternae, lacking of ribosomes, is shown in the cytoplasm (bar: 500 nm); d Long and narrow mitochondria
(m), with dense matrix and thin cristae, are observed in the cytoplasm. Extracellular vesicles (black arrow) and exosomes (black
arrowhead) are detected in the extracellular environment (bar: 1 μm). Adipose tissue MSCs (e) low magnification image showing a
cluster of MSCs with a spindle morphology, nucleus (N) and dark and dense nucleoli (n) (bar: 10 μm); f Golgi apparatus (black arrow)
and mitochondria (m) were observed in the cytoplasm (bar: 1 μm); g detail of the cytoplasm showing an extended RER (rer)
characterized by dilated cisternae almost empty of ribosomes (bar: 1 μm); (H) (bar: 500 nm); h Aggregated extracellular vesicles (black
arrow) are localized nearby cell membrane (bar: 500 nm)
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Study design
Three samples for each tissue type were used. Cell were
isolated, then doubling time was calculated from passage
0 (P0) to P3. At P3 all cells lines underwent adhesion
and migration assay, tri-lineage in vitro differentiation
plus tenogenic differentiation, immunofluorescence for
α-SMA and N-cadherin, RT-PCR for different genes,
and comparative ultrastructural morphology was investi-
gated by TEM.
Sample collection
UCB and WJ samples were recovered from foetal adnexa
immediately after parturition of three healthy mares
(Standardbred, 6–12 years old), housed at the Department
of Veterinary Medical Sciences, University of Bologna, for
attended delivery. Written informed consent from owners
was obtained to collect samples for research purposes.
BM was collected from three experimental horses
(Haflinger breed, 3 years old) at the Veterinary Teaching
Hospital, Department for Horses, University of Leipzig,
Germany. Bone marrow was collected from sedated
horses according to standard surgical procedures. The
sternal region was prepared aseptically, local anesthesia
was applied, the sternum was punctured with an 11 G
bone marrow aspiration needle and a sample was aspi-
rated into a heparinized syringe. Horses were then
euthanized for unrelated reasons and subcutaneous
adipose tissue was collected via skin incision from the
supragluteal region. Tendon samples, to induce the
tenogenic differentiation in a transwell coculture system,
were aseptically collected from the superficial digital
flexor tendons of equine distal limbs collected at an
abattoir, and immediately frozen at − 80 °C.
Cell isolation and calculation of cell doubling time
Samples were stored in DPBS (Dulbecco’s Phosphate
Buffered Solution) supplemented with antibiotics (100
IU/mL penicillin and 100 μg/mL streptomycin), at 4 °C,
until processing. In the lab, cells were isolated as previ-
ously described [7, 13]. Briefly, mononuclear cells were
separated from UCB and BM by standard density gradient
centrifugation using a polysaccharide solution (Ficoll-Paque
Premium, GE Healthcare). AT was minced and digested in
a collagenase I solution (Invitrogen) (0,8mg/ml) at 37 °C
for 4 h; WJ was minced and digested in DPBS containing
0.1% collagenase (w/v) (GIBCO®, Invitrogen Corporation,
Carlsbad, California, USA) by incubation at 37 °C for 20–
30min. Isolated BM and AT cells were seeded into culture
Fig. 9 Morphometric analysis of equine adult and foetal adnexa mesenchymal stem cells (MSCs). Histograms represent means and standard
deviations for (a) cellular area, b nuclear area, c number of microvesicles, d diameter of microvesicles, e area of microvesicles, f Golgi’s vesicles
number, g Golgi’s vesicles diameter, h number of mitochondria, i area of mitochondria. Different letters mean significant differences (P < 0.05)
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flasks containing low concentration glucose (1 g/L) Dulbec-
co’s modified Eagle medium (DMEM) (Invitrogen), supple-
mented with 20% foetal bovine serum (FBS) (Sigma
Aldrich), 100 IU/mL penicillin, 0.1mg/mL streptomycin
(1% penicillin–streptomycin) and 0.05mg/mL gentamycin,
and incubated in a 5% CO2 humidified atmosphere at
37.0 °C. UCB and WJ isolated cells were seeded in culture
flasks containing DMEM-F12 Glutamax® (Gibco) supple-
mented with 10% (v/v) FBS (Gibco, Waltham, MA, USA)
and antibiotics (100 IU/mL penicillin and 100 μg/mL
streptomycin). Primary cells were plated in a 25 cm2 flask
in culture medium and incubated in a 5% CO2 humidified
atmosphere at 38.5 °C.
At 80–90% of confluence, cells were dissociated by
0.25% trypsin, counted and cryopreserved in case of BM
and AT cells. Passage 1 (P1) cells were then plated at the
concentration of 5 × 103 cells/cm2, and so on until P3,
culturing all cell lines in DMEM-F12 + antibiotics + 10%
FBS. DT and CDs and cell culture time (CT) were calcu-
lated from hemocytometer counts for each passage
according to the following two formulae [49]:
CD ¼ ln Nf=Nið Þ= ln 2ð Þ
DT ¼ CT=CD
where Nf and Ni are the final and initial number of
cells, respectively.
Adhesion and migration assays
In order to define differences between adult and foetal
adnexa derived MSCs, spheroid formation and migration
test were performed at P3. For adhesion assay, cells were
cultured in ‘hanging drops’ (5000 cells/drop) for 24 h.
That method provides information about the direct cell-
cell adhesion architecture found in normal tissues,
differently from the cell-substratum adhesion, performed
on monolayer cultures adherent to rigid substrates.
Images were acquired by a Nikon Eclipse TE 2000-U
inverted microscope. Spheroid areas were determined
using ImageJ software Version 1.6. Starting from the bin-
ary masks obtained by Image J, the volume of each
spheroid was computed using ReViSP [50], a software
specifically designed to accurately estimate the volume
of spheroids and to render an image of their 3D surface.
To assess cell migration potential, a scratch assay was
carried out. Cells (4.8 × 104) were seeded on 35 mm petri
dishes and cultured until confluence in the same condi-
tions as previously described. Scratches were made using
1 mL pipette tips, washed with medium and allowed to
grow for additional 24 h. Immediately after the scratch
and at the end of the culture, cells were observed under
an inverted light microscope (Eclipse TE 2000u, Nikon
Instruments Spa, Florence, Italy) and photographed in
the same area (marked in the plate) by CCD camera
(Visicam 3.0, VWR International Srl, Milan, Italy; DS-
Fi2, Nikon Instruments Spa, Florence, Italy). Gap dis-
tance of the wound was measured using Image J software
(Version 1.48 s; National Institutes of Health, USA). The
migration percentages were calculated using the following
formula:
[(distance at time 0–distance at 24 h)*100]/distance at
time 0.
In vitro differentiation
At P3, in vitro differentiation potential of cells monolayers
towards osteogenic, adipogenic, chondrogenic and teno-
genic lineages was studied. Cells (5000 cells /cm2) were
cultured under specific induction media. Adipogenic
medium: DMEM/F12 plus antibiotics + 15% (v/v) rabbit
serum + 1 μmol/l dexamethasone (removed after 6 days) +
0.5mmol/l IBMX (3-isobutyl-1-methylxanthine) (removed
after 3 days), 10 μg/ml insulin, 0.2mmol/l indomethacin.
Chondrogenic medium: DMEM/F12 plus antibiotics + 1%
(v/v) FBS + 6.25 μg/ml insulin + 50 nM AA2P (2-phospho-
L-ascorbic acid trisodium salt), 0.1 μmol/l dexamethasone,
10 ng/ml hTGFβ1 (human transforming growth factor β1).
Osteogenic medium: DMEM/F12 plus antibiotics + 10% (v/
v) FBS + 10mmol/l β-glycerophosphate + 0.1 μmol/l dexa-
methasone + 50 μmol/l AA2P. Tenogenic differentiation
was induced as described by Lovati et al. (2012) [51].
Briefly, tendon fragments of 2 to 3mm3 were seeded on the
upper membrane (pore size of 0.4 μm) of a transwell
chamber (Corning Costar, Cambridge, MA, USA) and co-
cultured with 500 MSCs /cm2 seeded on the bottom of 6-
well culture plates. 3ml of serum-free medium were added
to cover both the upper tendon pieces and the lower mono-
layer of MSCs.
Control samples consisted in MSCs cultured for the
same period of time in DMEM/F12 plus 2% (v/v) FBS.
To assess differentiation, cells were fixed with 4% (w/
v) paraformaldehyde, and then stained. Oil Red O (0.3%
(v/v) in 60% (v/v) isopropanol) was used to evaluate
formation of neutral lipid vacuoles after 10 days of
adipogenic differentiation. Chondrogenic and osteogenic
differentiation were assessed after 21 days of culture in
induction media by using 1% (w/v) Alcian Blue in 3% (v/
v) acetic acid solution and Von Kossa (1% (w/v) silver
nitrate in water), respectively. Tenogenic differentiation
was assessed after 15 days of culture using 2% (w/v)
Aniline Blue in water.
Cells were observed under an inverted light microscope
(Eclipse TE 2000u, Nikon Instruments Spa, Florence, Italy)
and photographed by CCD camera (DS-Fi2, Nikon Instru-
ments Spa, Florence, Italy).
IF
Cells at P3 were fixed with 4% paraformaldehyde, then
washed in phosphate buffer (PB). Cells were permebilized
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in 0.5% (v/v) Triton-X100 for 15min and then blocked in
goat serum (10%) for 1 h and incubated overnight with
primary antibodies (rabbit polyclonal α-SMA 1:500 (Gene
tex, Milan, Italy); rabbit polyclonal N-Cadherin 1:1000
(Biorbyt, Milan, Italy)). Cells were separately labelled with
primary anbodies. Cross-reactivity of antibodies for the
horse was previously tested in our laboratory on horse
fibroblasts. Cells were then washed in PB2 (PB + 0.2% (w/v)
BSA+ 0.05 (w/v) % saponin) and incubated with goat anti-
rabbit- FITC conjugated secondary antibody (Merck, Milan,
Italy) 1:200 for 1 h. Nuclei were then labelled with Hoechst
33342 for fetal-MSCs and DAPI for adult-MSCs. The
excess of secondary antibody and Hoechst/DAPI were
removed by three washes with PB2. Images of MSCs were
Table 2 Sequence, source, amplicon size of primers used for PCR analysis. Primers are grouped in different categories
Primers References Sequences (5′→ 3′) bp
Mesenchymal markers
CD90 [52] FW: TGCGAACTCCGCCTCTCT 93
RW: GCTTATGCCCTCGCACTTG




CD34 [52] FW: CACTAAACCCTCTACATCATTTTCTCCTA 101
RW: GGCAGATACCTTGAGTCAATTTCA
CD45 [52] FW: TGATTCCCAGAAATGACCATGTA 101
RW: ACATTTTGGGCTTGTCCTGTAAC
Major histocompatibility complex markers
MHC1 [53] FW: GGAGAGGAGCAGAGATACA 218
RW: CTGTCACTGTTTGCAGTCT
MHC2 [53] FW: TCTACACCTGCCAAGTG 178
RW: CCACCATGCCCTTTCTG
Pro- and anti-inflammatory cytokines
TNFα [54] FW: GCTCCAGACGGTGCTTGTG 95
RW: GCCGATCACCCCAAAGTG
IL8 [54] FW: CGGTGCCAGTGCATCAAG 81
RW: TGGCCCACTCTCAATCACTCT
INFγ [55] FW: GTGTGCGATTTTGGGTTCTTCTA 235
RW: TTGAATGACCTGGTTATCT
IL4 [55] FW: CAACTTCATCCAGGGATGCAA 107
RW: CAGTCAGCTCCATGCACGAAT
ILβ1 [55] FW: GAGGCAGCCATGGCAGCAGTA 257
RW: TGTGAGCAGGGAACGGGTATCTT
IL6 [56] FW: AAACCACCTCAAATGGACCACTA 91
RW: TTTTTCAGGGCAGAGATTTTGC
Pluripotency markers
OCT4 [36] FW: TCCCAGGACATCAAAGCTCTGCAGA 679
RW: TCAGTTTGAATGCATGGGAGAAGCCCAGA
NANOG [36] FW: GACAGCCCCGATTCATCCACCAG 492
RW: GCACCAGGTCTGACTGTTCCAGG
SOX2 [36] FW: GGCGGCAACCAGAAGAACAG 663
RW: AGAAGAGGTAACCACGGGGG
Housekeeping
GAPDH [36] FW: GTCCATGCCATCACTGCCAC 262
RW: CCTGCTTCACCACCTTCTTG
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obtained with a Nikon Eclipse E400 microscope (Nikon
Instruments Spa, Florence, Italy) using the software Nikon
NIS-Elements.
RT-PCR
At P3 105 cells were snap-frozen and RNA was extracted
using Nucleo Spin® RNA kit (Macherey-Nagel) following
the manufacturer’s instructions. cDNAs were synthesized
by RevertAid RT Kit (ThermoFisher Scientific) and used
directly in PCR reactions, following the instructions of
Maxima Hot Start PCR Master Mix (ThermoFisher Scien-
tific). Expression of genes coding for MSC markers (CD90
and CD73), hematopoietic markers (CD34 and CD45),
major histocompatibility complex (MHC) markers (MHC1
and MHC2), pro- and anti-inflammatory cytokines (TNFα,
IL8, INFγ, IL4, ILβ1, IL6) and pluripotency markers
(OCT4, SOX2, NANOG) were investigated. GAPDH was
used as housekeeping gene to ensure proper expression of
samples. Primers used are listed in Table 2. PCR products
were visualized with ethidium bromide on a 2% (w/v)
agarose gel.
TEM
At P3 equine UCB, WJ, AT and BM-MSCs were fixed
with 2.5% (v/v) glutaraldehyde in 0.1M cacodylate buffer
for 2 h at 4 °C and post fixed with a solution of 1% (w/v)
osmium tetroxide in 0.1M cacodylate buffer for 1 h at
room temperature. Then, cells were embedded in epoxy
resins after a graded-acetone serial dehydration step.
The embedded samples were sectioned into ultrathin
slices, stained with uranyl acetate and lead citrate solu-
tions, and then observed by transmission electron
microscope CM10 Philips (FEI Company, Eindhoven,
The Netherlands) at an accelerating voltage of 80 kV.
Images were recorded by Megaview III digital camera
(FEI Company, Eindhoven, The Netherlands).
Morphometric analysis
Morphometric analysis was carried out on 100 nm ultra-
thin slices by ITEM software (FEI Company, Eindhoven,
The Netherlands). For cell area, 10 cell sections from each
sample, from 5 to 6 randomly chosen regions, were ac-
quired at 800 X and cell area was calculated for each cell
and expressed as average value. For nuclear area, 10 cell
sections from each sample, from 5 to 6 randomly chosen
regions, were acquired at 3400X and the nuclear area was
calculated in each section and expressed as average value.
For the number of microvesicles, 10 cell sections from
each sample, from 5 to 6 randomly chosen regions, were
acquired at 19.000X and the number of microvesicles was
calculated in each image and expressed as mean number
of vesicles/field. For the diameter and area of microvesi-
cles, from each sample, 20 randomly images of cytoplasm
were acquired at 19000X and the diameter and area of the
vesicle was calculated in each image and expressed as
average value. For mitochondria number, 30 cell sections
for each sample, from 5 to 6 randomly chosen regions,
were acquired at 19.000X, calculated and the result was
expressed as mean number of mitochondria/field. For
mitochondrial area, 30 cell sections from each sample,
from 5 to 6 randomly chosen regions, were acquired at
19.000X and mitochondrial area was calculated in each
image and expressed as average value.
Statistical analysis
Data are expressed as mean ± standard deviation (SD).
Statistical analyses were performed using IBM SPSS Statis-
tics 23 (IBM Corporation, Milan, Italy). Data were checked
for normal distribution using a Shapiro-Wilk test, and then
analysed using a one-way ANOVA or a Kruskal-Wallis
Test. Bonferroni’s test was used for post hoc comparison.
Student T-test was used for a further comparison of groups
in the migration assay. For number of microvesicles and
mitochondria, data were checked for Poisson distribution
and then analysed using a Poisson regression. Significance
was assessed for P < 0.05.
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